{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:20:32Z","timestamp":1791534032160,"version":"4.3.4"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T00:00:00Z","timestamp":1478736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ijid.2016.11.006","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T21:01:18Z","timestamp":1479502878000},"page":"68-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"special_numbering":"C","title":["Preventive therapy for latent tuberculosis infection\u2014the promise and the challenges"],"prefix":"10.1016","volume":"56","author":[{"given":"G.J.","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.C.","family":"Dobler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Marais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.","family":"Denholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2016.11.006_bib0005","series-title":"Global tuberculosis report 2015","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.ijid.2016.11.006_bib0010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ijid.2016.11.006_bib0015","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1164\/ajrccm.162.5.2004154","article-title":"Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: reappraising the estimates of risk","volume":"162","author":"Marks","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0020","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Getahun","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0025","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/jech.2003.008664","article-title":"To control and beyond: moving towards eliminating the global tuberculosis threat","volume":"58","author":"Brewer","year":"2004","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.ijid.2016.11.006_bib0030","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO's new end TB strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.11.006_bib0035","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(15)00323-2","article-title":"Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection","volume":"386","author":"Rangaka","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.11.006_bib0040","doi-asserted-by":"crossref","first-page":"e1005739","DOI":"10.1371\/journal.ppat.1005739","article-title":"PET CT identifies reactivation risk in cynomolgus macaques with latent M. tuberculosis","volume":"12","author":"Lin","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2016.11.006_bib0045","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology of intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2016.11.006_bib0050","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.chest.2015.11.017","article-title":"Risk of active tuberculosis in the five years following infection\u202615%?","volume":"149","author":"Trauer","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2016.11.006_bib0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1183\/09031936.00070812","article-title":"Contact investigation for tuberculosis: a systematic review and meta-analysis","volume":"41","author":"Fox","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2016.11.006_bib0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cid\/ciu748","article-title":"A prospective evaluation of the symptom-based screening approach to the management of children who are contacts of tuberculosis cases","volume":"60","author":"Triasih","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0065","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/thoraxjnl-2015-207687","article-title":"The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection","volume":"71","author":"Seddon","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2016.11.006_bib0070","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.otohns.2008.01.022","article-title":"Treatment outcomes for nontuberculous mycobacterial cervicofacial lymphadenitis in children based on the type of surgical intervention","volume":"138","author":"Wei","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijid.2016.11.006_bib0075","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/INF.0b013e318214b915","article-title":"The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis","volume":"30","author":"Machingaidze","year":"2011","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.ijid.2016.11.006_bib0080","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1183\/13993003.01464-2015","article-title":"Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection","volume":"47","author":"Hoff","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2016.11.006_bib0085","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2016.11.006_bib0090","series-title":"Tuberculosis: NICE guideline (NG33)","author":"National Institute of Health and Care Excellence","year":"2016"},{"key":"10.1016\/j.ijid.2016.11.006_bib0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","article-title":"Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States","volume":"189","author":"Dorman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0100","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0105","series-title":"Guidelines on the management of latent tuberculosis infection. WHO\/HTM\/TB\/2015. 01","author":"World Health Organization","year":"2014"},{"issue":"2","key":"10.1016\/j.ijid.2016.11.006_bib0110","first-page":"CD001363","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2016.11.006_bib0115","first-page":"CD008597","article-title":"Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis","volume":"3","author":"Adamu","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2016.11.006_bib0120","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0125","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/QAD.0000000000001098","article-title":"Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons","volume":"30","author":"Sterling","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2016.11.006_bib0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","article-title":"Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid","volume":"169","author":"Villarino","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ijid.2016.11.006_bib0135","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-149-10-200811180-00003","article-title":"Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial","volume":"149","author":"Menzies","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMoa1214289","article-title":"A trial of mass isoniazid preventive therapy for tuberculosis control","volume":"370","author":"Churchyard","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0150","doi-asserted-by":"crossref","first-page":"899","DOI":"10.5588\/ijtld.14.0007","article-title":"Mass treatment to eliminate tuberculosis from an island population","volume":"18","author":"Hill","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0155","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis. A general review","volume":"26","author":"Ferebee","year":"1970","journal-title":"Bibl Tuberc"},{"key":"10.1016\/j.ijid.2016.11.006_bib0160","first-page":"161","article-title":"A controlled trial of isoniazid prophylaxis in mental institutions","volume":"88","author":"Ferebee","year":"1963","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0165","first-page":"821","article-title":"The effect of isoniazid prophylaxis on tuberculosis morbidity among household contacts of previously known cases of tuberculosis","volume":"85","author":"Mount","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0170","first-page":"490","article-title":"Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts","volume":"85","author":"Ferebee","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0175","first-page":"935","article-title":"A controlled trial of community-wide isoniazid prophylaxis in Alaska","volume":"95","author":"Comstock","year":"1967","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7326\/M14-1019","article-title":"Treatment of latent tuberculosis infection: a network meta-analysis","volume":"161","author":"Stagg","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0185","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"Comstock","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0190","first-page":"S221","article-title":"Targeted tuberculin testing and treatment of latent tuberculous infection","volume":"161","author":"American Thoracic Society and Centers for Disease Control and Prevention","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0195","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1183\/09031936.00203811","article-title":"European Union standards for tuberculosis care","volume":"39","author":"Migliori","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2016.11.006_bib0200","series-title":"Canadian tuberculosis standards","author":"Public Health Agency of Canada","year":"2013"},{"key":"10.1016\/j.ijid.2016.11.006_bib0205","first-page":"735","article-title":"Update: adverse event data and revised American Thoracic Society\/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection\u2014United States, 2003","volume":"52","author":"Centers for Disease Control and Prevention, American Thoracic Society","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2016.11.006_bib0210","doi-asserted-by":"crossref","first-page":"633","DOI":"10.5588\/ijtld.11.0504","article-title":"Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial","volume":"16","author":"Chan","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/ajrccm\/145.1.36","article-title":"A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service\/Tuberculosis Research Centre. Madras\/British Medical Research Council","volume":"145","author":"Hong Kong Chest Service","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0220","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1164\/rccm.200404-478OC","article-title":"Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months","volume":"170","author":"Menzies","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.ijid.2016.11.006_bib0225","first-page":"CD007545","article-title":"Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB","author":"Sharma","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2016.11.006_bib0230","unstructured":"Clinicaltrials.gov. Randomized clinical trial comparing 4RIF vs. 9INH for LTBI treatment-effectiveness 2016, Dr Dick Menzies, McGill University. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00931736?term=NCT00931736&rank=1 (accessed September 8, 2016)."},{"issue":"RR\u201315","key":"10.1016\/j.ijid.2016.11.006_bib0235","first-page":"1","article-title":"Guidelines for the investigation of contacts of persons with infectious tuberculosis","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ijid.2016.11.006_bib0240","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000001329","article-title":"Twelve-week rifapentine plus isoniazid versus 9-month isoniazid for the treatment of latent tuberculosis in renal transplant candidates","author":"Simkins","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.ijid.2016.11.006_bib0245","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/427802","article-title":"Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis","volume":"40","author":"Ena","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0250","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/520983","article-title":"The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study","volume":"45","author":"Spyridis","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0255","first-page":"257","article-title":"Recent developments in treatment of latent tuberculosis infection","volume":"133","author":"Menzies","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijid.2016.11.006_bib0260","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","article-title":"Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial","volume":"283","author":"Gordin","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ijid.2016.11.006_bib0265","first-page":"289","article-title":"Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection\u2014New York and Georgia, 2000","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2016.11.006_bib0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(10)61972-1","article-title":"Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study","volume":"377","author":"Becerra","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.11.006_bib0275","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.5588\/ijtld.12.0092","article-title":"Long-term follow-up of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995\u20132010","volume":"16","author":"Denholm","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0280","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.13.0028","article-title":"Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009\u20132012","volume":"18","author":"Bamrah","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0285","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cid\/cit655","article-title":"Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study","volume":"57","author":"Seddon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0290","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.109.5.765","article-title":"Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up","volume":"109","author":"Schaaf","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2016.11.006_bib0295","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/INF.0000000000000260","article-title":"Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis","volume":"33","author":"Adler-Shohet","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijid.2016.11.006_bib0300","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/thx.2008.100974","article-title":"Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: a nationwide cohort","volume":"64","author":"Attamna","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2016.11.006_bib0305","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/INF.0b013e3181783aca","article-title":"Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003","volume":"27","author":"Feja","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijid.2016.11.006_bib0310","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/civ156","article-title":"Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial","volume":"60","author":"Torre-Cisneros","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0315","series-title":"Latent tuberculosis infection: a guide for primary health care providers","author":"Centers for Disease Control and Prevention","year":"2016"},{"issue":"3P1","key":"10.1016\/j.ijid.2016.11.006_bib0320","first-page":"352","article-title":"Reactivations in inactive pulmonary tuberculosis","volume":"93","author":"Grzybowski","year":"1966","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0325","first-page":"431","article-title":"Active tuberculosis after isoniazid chemoprophylaxis of Southeast Asian refugees","volume":"133","author":"Nolan","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0330","first-page":"605","article-title":"Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service","volume":"104","author":"Grzybowski","year":"1971","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0335","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00002030-199310000-00007","article-title":"A prospective study of the risk of tuberculosis among HIV-infected patients","volume":"7","author":"Guelar","year":"1993","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2016.11.006_bib0340","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jama.1995.03530020061033","article-title":"Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)","volume":"274","author":"Antonucci","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2016.11.006_bib0345","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0350","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","article-title":"The prognosis of a positive tuberculin reaction in childhood and adolescence","volume":"99","author":"Comstock","year":"1974","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2016.11.006_bib0355","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/annrheumdis-2011-200690","article-title":"Mycobacterial diseases and antitumour necrosis factor therapy in USA","volume":"72","author":"Winthrop","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0360","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijid.2016.11.006_bib0365","doi-asserted-by":"crossref","first-page":"e29563","DOI":"10.1371\/journal.pone.0029563","article-title":"Risk of tuberculosis in dialysis patients: a nationwide cohort study","volume":"6","author":"Dobler","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl 7","key":"10.1016\/j.ijid.2016.11.006_bib0370","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1469-0691.12641","article-title":"Mycobacterial infections in solid organ transplant recipients","volume":"20","author":"Meije","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2016.11.006_bib0375","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.transproceed.2006.03.029","article-title":"Mycobacterium tuberculosis infection in renal transplant recipients","volume":"38","author":"Ergun","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijid.2016.11.006_bib0380","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhin.2005.09.020","article-title":"Tuberculosis in stem cell transplant patients","volume":"62","author":"Akan","year":"2006","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijid.2016.11.006_bib0385","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(12)60235-9","article-title":"Silicosis","volume":"379","author":"Leung","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.11.006_bib0390","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1097\/00002030-200012010-00016","article-title":"HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners","volume":"14","author":"Corbett","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2016.11.006_bib0395","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijid.2016.11.006_bib0400","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/oxfordjournals.aje.a112105","article-title":"Frost revisited: the modern epidemiology of tuberculosis","volume":"101","author":"Comstock","year":"1975","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2016.11.006_bib0405","doi-asserted-by":"crossref","first-page":"e000666","DOI":"10.1136\/bmjopen-2011-000666","article-title":"Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study","volume":"2","author":"Dobler","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2016.11.006_bib0410","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0415","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/aje\/kwn075","article-title":"Diabetic control and risk of tuberculosis: a cohort study","volume":"167","author":"Leung","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2016.11.006_bib0420","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0962-8479(95)90529-4","article-title":"Incidence of pulmonary tuberculosis among diabetics","volume":"76","author":"Kim","year":"1995","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0425","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1183\/09031936.00072909","article-title":"Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD","volume":"35","author":"van Zyl Smit","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2016.11.006_bib0430","first-page":"942","article-title":"Smoking and tuberculosis: an association overlooked","volume":"6","author":"Maurya","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0435","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1378\/chest.13-2137","article-title":"Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: a systematic review and meta-analysis of randomized controlled trials","volume":"145","author":"Dong","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2016.11.006_bib0440","doi-asserted-by":"crossref","first-page":"e1002072","DOI":"10.1371\/journal.pmed.1002072","article-title":"Glycemic control and the risk of tuberculosis: a cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0445","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJMsa0707719","article-title":"A nationally representative case\u2013control study of smoking and death in India","volume":"358","author":"Jha","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0450","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ccm.2009.08.012","article-title":"Screening and preventive therapy for tuberculosis","volume":"30","author":"Marais","year":"2009","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0455","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: US Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2016.11.006_bib0460","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1473-3099(11)70069-X","article-title":"Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis","volume":"11","author":"Pareek","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0465","doi-asserted-by":"crossref","first-page":"458","DOI":"10.5694\/mja12.10035","article-title":"Risk of active tuberculosis in immigrants: effects of age, region of origin and time since arrival in a low-exposure setting","volume":"197","author":"McBryde","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.ijid.2016.11.006_bib0470","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1186\/s12889-015-2530-7","article-title":"A cost\u2013benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program","volume":"15","author":"Wingate","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijid.2016.11.006_bib0475","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1753-6405.2012.00895.x","article-title":"Ethical evaluation of immigration screening policy for latent tuberculosis infection","volume":"36","author":"Denholm","year":"2012","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.ijid.2016.11.006_bib0480","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"Solovic","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2016.11.006_bib0485","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1183\/13993003.00577-2015","article-title":"Benefit of treatment of latent tuberculosis infection in individual patients","volume":"46","author":"Dobler","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2016.11.006_bib0490","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0495","first-page":"180ra49","article-title":"Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis","volume":"5","author":"Mills","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0500","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1403494809353823","article-title":"Screening and treatment of latent tuberculosis in a cohort of asylum seekers in Norway","volume":"38","author":"Harstad","year":"2010","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ijid.2016.11.006_bib0505","doi-asserted-by":"crossref","first-page":"e76552","DOI":"10.1371\/journal.pone.0076552","article-title":"What patient factors predict physicians\u2019 decision not to treat latent tuberculosis infection in tuberculosis contacts?","volume":"8","author":"Dobler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2016.11.006_bib0510","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1183\/09031936.00183812","article-title":"Risk of tuberculosis among contacts in a low-incidence setting","volume":"41","author":"Dobler","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2016.11.006_bib0515","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/adc.2006.097220","article-title":"Adherence to isoniazid preventive chemotherapy: a prospective community based study","volume":"91","author":"Marais","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ijid.2016.11.006_bib0520","first-page":"CD009756","article-title":"Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection","volume":"3","author":"Horvath","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijid.2016.11.006_bib0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0272989X0002000101","article-title":"Evaluation of an Internet-based decision-support system for applying the ATS\/CDC guidelines for tuberculosis preventive therapy","volume":"20","author":"Dayton","year":"2000","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ijid.2016.11.006_bib0530","first-page":"498","article-title":"Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results","volume":"12","author":"Menzies","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2016.11.006_bib0535","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1183\/13993003.00175-2016","article-title":"Benefit of treatment of latent tuberculosis infection in individual patients","volume":"47","author":"Dobler","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2016.11.006_bib0540","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-publhealth-031912-114431","article-title":"Prospects for tuberculosis elimination","volume":"34","author":"Dye","year":"2013","journal-title":"Ann Rev Public Health"},{"key":"10.1016\/j.ijid.2016.11.006_bib0545","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.11.006_bib0550","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1164\/rccm.201501-0069OC","article-title":"Fluoroquinolone therapy for the prevention of multidrug-resistant tuberculosis in contacts. A cost-effectiveness analysis","volume":"192","author":"Fox","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2016.11.006_bib0555","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.5588\/ijtld.15.0066","article-title":"Sociocultural dimensions of tuberculosis: an overview of key concepts","volume":"19","author":"Mason","year":"2015","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216312231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216312231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:01:28Z","timestamp":1692576088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971216312231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":111,"alternative-id":["S1201971216312231"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2016.11.006","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventive therapy for latent tuberculosis infection\u2014the promise and the challenges","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2016.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}